Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Ishiwatari-Ogata, Chihiro
6  Ergebnisse:
Personensuche X
?
1

Ozoralizumab, a Humanized Anti-TNFα NANOBODY® Compound, Exh..:

Ishiwatari-Ogata, Chihiro ; Kyuuma, Masanao ; Ogata, Hitoshi...
Frontiers in Immunology.  13 (2022)  - p. , 2022
Link: https://doi.org/10.3389/..
 
?
2

Ozoralizumab, a Humanized Anti-TNFα NANOBODY(®) Compound, E..:

Ishiwatari-Ogata, Chihiro ; Kyuuma, Masanao ; Ogata, Hitoshi...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8902368/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
3

Ozoralizumab, a Humanized Anti-TNFα NANOBODY® Compound, Exh..:

Chihiro Ishiwatari-Ogata ; Masanao Kyuuma ; Hitoshi Ogata...
https://www.frontiersin.org/articles/10.3389/fimmu.2022.853008/full.  , 2022
Link: https://doi.org/10.3389/..
 
?
4

DataSheet_1_Ozoralizumab, a Humanized Anti-TNFα NANOBODY® C..:

Chihiro Ishiwatari-Ogata ; Masanao Kyuuma ; Hitoshi Ogata...
doi:10.3389/fimmu.2022.853008.s001.  , 2022
Link: https://doi.org/10.3389/..
 
?
5

Asymmetric dimethylarginine accumulation under hyperglycemi..:

Kaneko, Yukiko K. ; Morioka, Ami ; Sano, Misaki...
Biochemical and Biophysical Research Communications.  637 (2022)  - p. 108-116 , 2022
Link: https://doi.org/10.1016/..
 
?
6

Diacylglycerol kinase δ functions as a proliferation suppre..:

Sato, Taiji ; Ishiwatari, Chihiro ; Kaneko, Yukiko K....
The FASEB Journal.  35 (2021)  5 - p. , 2021
Link: https://doi.org/10.1096/..
 
1-6